Haku Bio, Inc. — SEC Form D Filing

Haku Bio, Inc. filed an SEC Form D on March 2, 2026 in Health & Wellness.

Form D filing details

Filing
SEC Form D
Filing date
March 2, 2026
Industry
Health & Wellness
Website
https://hakuhealth.com/

Problem

Haku Bio addresses the challenges people face in maintaining a healthy lifestyle in a hyper-commercialized society.

Solution

Haku Bio offers an app that focuses on biohacking, providing resources on nutrition, sleep, fitness, supplements, and mindfulness to help users improve their health.

Why now

There is a growing demand for simplified health solutions amid increasing awareness of personal well-being.

Verdict

Investors found Haku Bio's narrative compelling due to the increasing consumer desire for accessible health solutions, which cleared because it tapped into the rising trend of biohacking, not because the competitive landscape was particularly favorable. They implicitly bet on the expansion of consumer health tech and a market eager for personalized solutions. However, the upside is limited by the saturated wellness app market, which diminishes durability against incumbents with established user bases.

Source: SEC EDGAR Form D filing